- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 15/02 - Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
Patent holdings for IPC class A61P 15/02
Total number of patents in this class: 473
10-year publication summary
|
17
|
14
|
17
|
32
|
44
|
56
|
55
|
49
|
41
|
22
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Kimberly-clark Worldwide, Inc. | 5854 |
11 |
| Polichem SA | 204 |
8 |
| Osel, Inc. | 17 |
7 |
| Singapore Ze&z International Pte. Ltd. | 10 |
7 |
| The Procter & Gamble Company | 22178 |
5 |
| Takeda Pharmaceutical Company Limited | 2961 |
5 |
| Ferring B.V. | 705 |
5 |
| Lakewood-amedex, Inc. | 24 |
5 |
| Probiotical S.p.A. | 241 |
5 |
| TherapeuticsMD, Inc. | 114 |
5 |
| The Johns Hopkins University | 5377 |
4 |
| ITF Research Pharma, S.L.U. | 16 |
4 |
| Kissei Pharmaceutical Co., Ltd. | 215 |
4 |
| Lunamed AG | 13 |
4 |
| Scynexis, Inc. | 69 |
4 |
| University of Rochester | 1243 |
4 |
| Mucosa Innovations, S.L. | 11 |
4 |
| Profem GmbH | 9 |
4 |
| Nexbiome Therapeutics | 7 |
4 |
| Allergan, Inc. | 2600 |
3 |
| Other owners | 371 |